J. Melena et al., BETAMETHASONE-INDUCED OCULAR HYPERTENSION IN RABBITS, Methods and findings in experimental and clinical pharmacology, 19(8), 1997, pp. 553-558
The effect of subconjunctivally injected betamethasone on intraocular
pressure (IOP) was studied in 85 albino New Zealand rabbits. IOP was m
easured with a Mentor Model 30 classic pneumatonograph that was manome
trically calibrated to the rabbit eye. Ocular hypertension was induced
by weekly subconjunctival injections of a betamethasone suspension in
to the left eye. In one experiment, 70 rabbits were given betamethason
e for 4 weeks, while a second group of 10 rabbits received betamethaso
ne for 11 weeks. The short-term effects of subconjunctival injections
of betamethasone on IOP were also recorded in a third group of 5 rabbi
ts. Weekly injections over 4 weeks resulted in an increase in IOP in t
he treated eye, which was prolonged to 11 weeks by repeated weekly inj
ections. A sustained increase in IOP was observed in the treated eye f
or a period of 7 weeks. During the early hours after betamethasone inj
ection, a transient decrease in IOP was registered in both eyes. The r
esults show that weekly subconjunctival injections of betamethasone ca
use a predictable increase in IOP in the treated eye which may be suit
able for testing the short- and long-term effects of antiglaucoma drug
s. Evidence suggesting that endogenous glucocorticoids may play a role
in the development of ocular hypertension in human strengths the pote
ntial value of this glaucoma model.